Free access
Issue
Vet. Res.
Volume 37, Number 1, January-February 2006
Page(s) 155 - 168
DOI http://dx.doi.org/10.1051/vetres:2005049
Published online 13 December 2005
How to cite this article Vet. Res. (2006) 155-168
References of Vet. Res. 37 (2006) 155-168
  1. Armengol E., Wiesmuller K.H., Wienhold D., Buttner M., Pfaff E., Jung G., Saalmuller A., Identification of T-cell epitopes in the structural and non-structural proteins of classical swine fever virus, J. Gen. Virol. 83 (2002) 551-560 [PubMed].
  2. Balmelli C., Ruggli N., McCullough K., Summerfield A., Fibrocytes are potent stimulators of anti-virus cytotoxic T cells, J. Leukoc. Biol. (2005) 923-933.
  3. Boisgerault F., Moron G., Leclerc C., Virus-like particles: a new family of delivery systems, Expert Rev. Vaccines 1 (2002) 101-109 [PubMed].
  4. Bouma A., de Smit A.J., de Kluijver E.P., Terpstra C., Moormann R.J., Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus, Vet. Microbiol. 66 (1999) 101-114 [CrossRef] [PubMed].
  5. Bouma A., de Smit A.J., De Jong M.C., de Kluijver E.P., Moormann R.J., Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus, Vaccine 18 (2000) 1374-1381 [CrossRef] [PubMed].
  6. Carbonetti N.H., Irish T.J., Chen C.H., O'Connell C.B., Hadley G.A., McNamara U., Tuskan R.G., Lewis G.K., Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway, Infect. Immun. 67 (1999) 602-607 [PubMed].
  7. Carrasco C.P., Rigden R.C., Schaffner R., Gerber H., Neuhaus V., Inumaru S., Takamatsu H., Bertoni G., McCullough K.C., Summerfield A., Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties, Immunology 104 (2001) 175-184 [PubMed].
  8. Dahle J., Liess B., Assessment of safety and protective value of a cell culture modified strain "C" vaccine of hog cholera/classical swine fever virus, Berl. Munch. Tierarztl. Wochenschr. 108 (1995) 20-25 [PubMed].
  9. De Haan L., Hearn A.R., Rivett A.J., Hirst T.R., Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway, Infect. Immun. 70 (2002) 3249-3258 [CrossRef] [PubMed].
  10. de Smit A.J., Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review, Vet. Q. 22 (2000) 182-188 [PubMed].
  11. Dewulf J., Laevens H., Koenen F., Mintiens K., de Kruif A., An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus, Vaccine 20 (2001) 86-91 [CrossRef] [PubMed].
  12. Edwards S., Fukusho A., Lefevre P.C., Lipowski A., Pejsak Z., Roehe P., Westergaard J., Classical swine fever: the global situation, Vet. Microbiol. 73 (2000) 103-119 [CrossRef] [PubMed].
  13. Floegel-Niesmann G., Classical swine fever (CSF) marker vaccine. Trial III. Evaluation of discriminatory ELISAs, Vet. Microbiol. 83 (2001) 121-136 [CrossRef] [PubMed].
  14. Greiser-Wilke I., Moennig V., Coulibaly C.O., Dahle J., Leder L., Liess B., Identification of conserved epitopes on a hog cholera virus protein, Arch. Virol. 111 (1990) 213-225 [CrossRef] [PubMed].
  15. Hulst M.M., Westra D.F., Wensvoort G., Moormann R.J., Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera, J. Virol. 67 (1993) 5435-5442 [PubMed].
  16. Inumaru S., Kokuho T., Denham S., Denyer M.S., Momotani E., Kitamura S., Corteyn A., Brookes S., Parkhouse R.M., Takamatsu H., Expression of biologically active recombinant porcine GM-CSF by baculovirus gene expression system, Immunol. Cell Biol. 76 (1998) 195-201 [PubMed].
  17. Knoetig S.M., Summerfield A., Spagnuolo-Weaver M., McCullough K.C., Immunopathogenesis of classical swine fever: role of monocytic cells, Immunology 97 (1999) 359-366 [PubMed].
  18. Lippolis J.D., Denis-Mize K.S., Brinckerhoff L.H., Slingluff C.L. Jr., Galloway D.R., Engelhard V.H., Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing pathways, Cell. Immunol. 203 (2000) 75-83 [CrossRef] [PubMed].
  19. Maloy K.J., Donachie A.M., Mowat A.M., Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS, Eur. J. Immunol. 25 (1995) 2835-2841 [PubMed].
  20. Mayer D., Thayer T.M., Hofmann M.A., Tratschin J.D., Establishment and characterisation of two cDNA-derived strains of classical swine fever virus, one highly virulent and one avirulent, Virus Res. 98 (2003) 105-116 [CrossRef] [PubMed].
  21. McCullough K.C., Schaffner R., Fraefel W., Kihm U., The relative density of CD44-positive porcine monocytic cell populations varies between isolations and upon culture and influences susceptibility to infection by African swine fever virus, Immunol. Lett. 37 (1993) 83-90 [CrossRef] [PubMed].
  22. Mittelholzer C., Moser C., Tratschin J.D., Hofmann M.A., Analysis of classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strains, Vet. Microbiol. 74 (2000) 293-308 [CrossRef] [PubMed].
  23. Moennig V., Introduction to classical swine fever: virus, disease and control policy, Vet. Microbiol. 73 (2000) 93-102 [CrossRef] [PubMed].
  24. Moormann R.J., Bouma A., Kramps J.A., Terpstra C., De Smit H.J., Development of a classical swine fever subunit marker vaccine and companion diagnostic test, Vet. Microbiol. 73 (2000) 209-219 [CrossRef] [PubMed].
  25. Pauly T., Elbers K., Konig M., Lengsfeld T., Saalmuller A., Thiel H.J., Classical swine fever virus-specific cytotoxic T lymphocytes and identification of a T cell epitope, J. Gen. Virol. 76 (1995) 3039-3049 [PubMed].
  26. Regnault A., Lankar D., Lacabanne V., Rodriguez A., Thery C., Rescigno M., Saito T., Verbeek S., Bonnerot C., Ricciardi-Castagnoli P., Amigorena S., Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization, J. Exp. Med. 189 (1999) 371-380 [CrossRef] [PubMed].
  27. Ruggli N., Tratschin J.D., Mittelholzer C., Hofmann M.A., Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA, J. Virol. 70 (1996) 3478-3487 [PubMed].
  28. Saatkamp H.W., Berentsen P.B., Horst H.S., Economic aspects of the control of classical swine fever outbreaks in the European Union, Vet. Microbiol. 73 (2000) 221-237 [CrossRef] [PubMed].
  29. Summerfield A., McCullough K.C., Porcine bone marrow myeloid cells: phenotype and adhesion molecule expression, J. Leukoc. Biol. 62 (1997) 176-185 [PubMed].
  30. Summerfield A., Guzylack-Piriou L., Schaub A., Carrasco C.P., Tache V., Charley B., McCullough K.C., Porcine peripheral blood dendritic cells and natural interferon-producing cells, Immunology 110 (2003) 440-449 [PubMed].
  31. Suradhat S., Intrakamhaeng M., Damrongwatanapokin S., The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection, Vet. Immunol. Immunopathol. 83 (2001) 177-189 [PubMed].
  32. Takahashi H., Takeshita T., Morein B., Putney S., Germain R.N., Berzofsky J.A., Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs, Nature 344 (1990) 873-875 [CrossRef] [PubMed].
  33. Terpstra C., Wensvoort G., The protective value of vaccine-induced neutralising antibody titres in swine fever, Vet. Microbiol. 16 (1988) 123-128 [CrossRef] [PubMed].
  34. Terpstra C., Bloemraad M., Gielkens A.L., The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus, Vet. Microbiol. 9 (1984) 113-120 [CrossRef] [PubMed].
  35. Terpstra C., Woortmeyer R., Barteling S.J., Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain, Dtsch. Tierarztl. Wochenschr. 97 (1990) 77-79 [PubMed].
  36. Van Oirschot J.T., Vaccinology of classical swine fever: from lab to field, Vet. Microbiol. 96 (2003) 367-384 [CrossRef] [PubMed].
  37. Van Rijn P.A., Bossers A., Wensvoort G., Moormann R.J., Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge, J. Gen. Virol. 77 (1996) 2737-2745 [PubMed].
  38. Van Zijl M., Wensvoort G., de Kluyver E., Hulst M., van der Gulden H., Gielkens A., Berns A., Moormann R., Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera, J. Virol. 65 (1991) 2761-2765 [PubMed].
  39. Zinkernagel R.M., Hengartner H., On immunity against infections and vaccines: credo 2004, Scand. J. Immunol. 60 (2004) 9-13 [PubMed].